A comparison between hepatic artery ligation and portal 5-Fu infusion versus 5-Fu intra arterial infusion for colorectal liver metastases

European Journal of Surgical Oncology

Volumn 29, Issue 5, 2003, Pages 459-466

  Naredi, P ^a   Oman M ^a   Blind, P J ^a   Lindner P ^b   Gustavsson, B ^b   Hafström, Larsolof ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

5 fluorouracil; Colorectal cancer; Intraarterial infusion; Liver metastases

Indexed keywords

ALLOPURINOL; ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MORPHINE DERIVATIVE; ONDANSETRON;

ABDOMINAL PAIN; ARTICLE; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEPATIC ARTERY LIGATION; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; LIVER TOXICITY; PORTAL VEIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA; THROMBOCYTOPENIA; TUMOR GROWTH;

EID: 0038338441     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(03)00002-7     Document Type: Article

References (14)

1. Advanced colorectal Cancer Metaanalysis Project, Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer evidence in terms of response rate. J Clin Oncology 1992; 10: 896-903.
2. Ragnhammar P, Hafström L, Nygren P, Glimelius B. A systematic overview of chemotherapy effects in colorectal cancer. Acta Oncologica 2001; 40: 282-308.
3. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomized trial of regional versus systemic continuous 5-flurodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206: 685-93.
4. Hohn DC, Stagg RJ, Friedman MA, Hannigan JF Jr., Rayner A, Ignoffo RJ, Acord P, Lewis BJ. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 1989; 7: 1646-54.
5. Martin JK Jr., O'Connell MJ, Wieand HS, Fitzgibbons RJ Jr., Mailliard JA, Rubin J, Nagorney DM, Tschetter LK, Krook JE. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg 1990; 125: 1022-7.
6. Kemeny N. Current approaches to metastatic colorectal cancer. Semin Oncol 1994; 21(4 Suppl. 7): 67-75.
7. Bensmaine MA, de Gramont A, Brienza S, Marty M, Levi F, Ducreux M, Francois E, Gamelin E, Bleiberg H, Bleuzen P, Simon J, Cvitkovic E. Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU) + /-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients. Eur J Cancer 2000; 36: 2335-43.
8. Douillard JY et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomized trial. Lancet 2000; 355: 1041-7.
9. Rougier R Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J, Salmon R, Julien M, Roullet Audy JC, Gallot D et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992; 10: 1112-8.
10. Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344: 1255-60.
11. Hafström L, Carlsson G. Arterial devascularisation procedures in the treatment of liver cancer. Ann Chir Gynaecol Suppl 1986; 200: 85-90.
12. Hafström L, Engaås B, Holmberg SB, Gustavsson B, Jonsson PE, Lindnér P, Naredi P, Tidebrant G. Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. A randomized clinical trial. Cancer 1994; 74: 2749-56.
13. Meta-Analysis Group in Cancer, Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. JNCI 1996; 88: 252-8.
14. Harmanatas A, Rotstein LE, Langer B. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver - is there a survival difference? Cancer 1996; 78: 1639-45.